David C. Harmon
- Pulmonary and Respiratory Medicine top 0.2%
- Sarcoma Diagnosis and Treatment 68
- Oncology top 0.5%
- Vascular Tumors and Angiosarcomas 26
- Drug Transport and Resistance Mechanisms 6
- Rheumatology top 0.5%
- Bone Tumor Diagnosis and Treatments 22
-
- Cardiac tumors and thrombi 13
-
- Lymphoma Diagnosis and Treatment 12
-
- Multiple Myeloma Research and Treatments 8
-
- Blood disorders and treatments 6
- Co-authors
- Francis J. HornicekHenry J. MankinEdwin ChoyThomas F. DeLaneyHerman D. SuitAndrew E. RosenbergG. Petur NielsenZhenfeng Duan
- Journals
- Cancer (14 papers)International Journal of Radiation Oncology*Biology*Physics (14 papers)Journal of Clinical Oncology (12 papers)
- Partner nations
- United StatesChinaSpain
In The Last Decade
David C. Harmon
126 papers receiving 6.9k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Pulmonary and Respiratory Medicine 4.6k
- Oncology 3.1k
- Rheumatology 1.6k
- Cardiology and Cardiovascular Medicine 1.3k
- Pathology and Forensic Medicine 948
Countries citing papers authored by David C. Harmon
This map shows the geographic impact of David C. Harmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Harmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Harmon more than expected).
Fields of papers citing papers by David C. Harmon
This network shows the impact of papers produced by David C. Harmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Harmon. The network helps show where David C. Harmon may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David C. Harmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2016 | 14 | |
| 3 | 2015 | 10 | |
| 4 | 2014 | 154 | |
| 5 | 2014 | 27 | |
| 6 | 2014 | 117 | |
| 7 | 2012 | 60 | |
| 8 | 2012 | 9 | |
| 9 | 2011 | 69 | |
| 10 | 2011 | 64 | |
| 11 | 2009 | 76 | |
| 12 | 2009 | 249 | |
| 13 | 2009 | 16 | |
| 14 | Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002breakdown → | 2007 | 531 |
| 15 | 2007 | 56 | |
| 16 | 2005 | 10 | |
| 17 | 2004 | 250 | |
| 18 | 2002 | 55 | |
| 19 | 1997 | 97 | |
| 20 | 1988 | 210 |
About David C. Harmon
David C. Harmon is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Oncology, Hematology and Cancer Research, having authored 128 papers that have together received 7.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (68 papers), Vascular Tumors and Angiosarcomas (26 papers), Bone Tumor Diagnosis and Treatments (22 papers), Cardiac tumors and thrombi (13 papers), Lymphoma Diagnosis and Treatment (12 papers), Multiple Myeloma Research and Treatments (8 papers), Drug Transport and Resistance Mechanisms (6 papers) and Blood disorders and treatments (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.6k citations), Oncology (3.1k citations), Rheumatology (1.6k citations), Cardiology and Cardiovascular Medicine (1.3k citations) and Pathology and Forensic Medicine (948 citations). David C. Harmon has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Francis J. Hornicek, Henry J. Mankin, Edwin Choy, Thomas F. DeLaney, Herman D. Suit, Andrew E. Rosenberg, G. Petur Nielsen, Zhenfeng Duan, Robert G. Maki and Mark C. Gebhardt. Their work appears in journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Journal of Orthopaedic Research® and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.